First Time Loading...

Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 7.12 AUD -0.28% Market Closed
Updated: May 10, 2024
MYX
/
Income Statement
/
Income from Continuing Operations

Mayne Pharma Group Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayne Pharma Group Ltd
Income from Continuing Operations Peer Comparison

Comparables:
RCE
NEU
BOT
PBP
C
CU6

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Mayne Pharma Group Ltd
ASX:MYX
Income from Continuing Operations
-AU$317.4m
CAGR 3-Years
-49%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Income from Continuing Operations
-AU$11.3m
CAGR 3-Years
5%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Income from Continuing Operations
AU$157.1m
CAGR 3-Years
N/A
CAGR 5-Years
120%
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Income from Continuing Operations
-AU$14.6m
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
-24%
Probiotec Ltd
ASX:PBP
Income from Continuing Operations
AU$8.7m
CAGR 3-Years
14%
CAGR 5-Years
17%
CAGR 10-Years
15%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Income from Continuing Operations
-AU$24.6m
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mayne Pharma Group Ltd's Income from Continuing Operations?
Income from Continuing Operations
-317.4m AUD

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Income from Continuing Operations amounts to -317.4m AUD.

What is Mayne Pharma Group Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-20%

Over the last year, the Income from Continuing Operations growth was -44%. The average annual Income from Continuing Operations growth rates for Mayne Pharma Group Ltd have been -49% over the past three years , -20% over the past five years .

ALPHA SPREAD
Join more than 135,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.